Here's What's Going On With Zomedica Shares

Zomedica Corp ZOM shares are trading lower by 13.9% to $0.32 Tuesday morning after the company reported second-quarter earnings results.

What Happened?

Zomedica reported quarterly losses of 1 cent per share. The company also reported $4.20 million in sales this quarter. This is a marked increase from sales of $15,690 in the same period last year.

Larry Heaton, Zomedica's Chief Executive Officer, commented: "The second quarter of 2022 was an exciting one for Zomedica as we both grew revenue organically and also executed on our acquisition strategy. We were pleased with our revenue growth to $4.2 million which reflects a 51% increase on a pro-forma basis, over the combined revenue of Zomedica and PulseVet as a standalone company of $2.8 million in the second quarter of last year.

See Also: Here's How Much You'd Have Now If You Invested $1,000 In Bitcoin, Ethereum And Dogecoin 5 Years Ago

According to data from Benzinga Pro, Zomedica has a 52-week high of $0.80 and a 52-week low of $0.18.